0QOI.L
Newron Pharmaceuticals S.p.A., a clinical stage biopharmaceutical company, focuses on the research and development of therapies for the treatment of central and peripheral nervous system, and pain in Italy and the United States. The company offers Xadago (safinamide) for the treatment of Parkinson's disease, as well as develops Xadago for the treatment of levodopa induced dyskinesia. It also develops Evenamide for Schizophrenia and treatment resistant schizophrenia; and Ralfinamide for orphan indication in neuropathic pain. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy.
Industry
Medical - Pharmaceuticals
IPO Date
2014-06-17
Stock Exchange
LSE
Ticker
0QOI.L
According to Newron Pharmaceuticals S.p.A.’s latest financial reports and current stock price. The company's current ROE is 1.67%. This represents a change of 270.38% compared to the average of 449.88% of the last 4 quarters.
The mean historical ROE of Newron Pharmaceuticals S.p.A. over the last ten years is 48.20%. The current 1.67% ROE has changed 3.36% with respect to the historical average. Over the past ten years (40 quarters), 0QOI.L's ROE was at its highest in in the December 2024 quarter at 1.74%. The ROE was at its lowest in in the December 2021 quarter at -187.90%.
Average
48.20%
Median
-29.02%
Minimum
-479.59%
Maximum
1.09%
Discovering the peaks and valleys of Newron Pharmaceuticals S.p.A. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.90%
Maximum Annual ROE = 1.09%
Minimum Annual Increase = -126.00%
Minimum Annual ROE = -479.59%
| Year | ROE | Change |
|---|---|---|
| 2024 | 1.09% | 1.90% |
| 2023 | 54.25% | -56.49% |
| 2022 | 124.68% | -126.00% |
| 2021 | -479.59% | 293.90% |
| 2020 | -121.76% | 121.72% |
| 2019 | -54.91% | 100.28% |
| 2018 | -27.42% | 251.53% |
| 2017 | -7.80% | -74.54% |
| 2016 | -30.63% | -50.18% |
| 2015 | -61.48% | 78.20% |
The current ROE of Newron Pharmaceuticals S.p.A. (0QOI.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
421.85%
5-year avg
132.84%
10-year avg
48.20%
Newron Pharmaceuticals S.p.A.’s ROE is greater than DocMorris AG (-29.46%), greater than COLTENE Holding AG (14.37%), greater than IVF Hartmann Holding AG (12.79%), greater than Metall Zug AG (-3.15%), greater than Santhera Pharmaceuticals Holding AG (-521.53%), greater than Molecular Partners AG (-50.31%), greater than Ascom Holding AG (4.09%), greater than Relief Therapeutics Holding AG (-49.18%), less than Basilea Pharmaceutica AG (70.33%), greater than Addex Therapeutics Ltd (-66.77%),
| Company | ROE | Market cap |
|---|---|---|
| -29.46% | N/A | |
| 14.37% | N/A | |
| 12.79% | N/A | |
| -3.15% | N/A | |
| -521.53% | N/A | |
| -50.31% | N/A | |
| 4.09% | N/A | |
| -49.18% | N/A | |
| 70.33% | N/A | |
| -66.77% | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Newron Pharmaceuticals S.p.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Newron Pharmaceuticals S.p.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Newron Pharmaceuticals S.p.A.'s ROE?
How is the ROE calculated for Newron Pharmaceuticals S.p.A. (0QOI.L)?
What is the highest ROE for Newron Pharmaceuticals S.p.A. (0QOI.L)?
What is the 3-year average ROE for Newron Pharmaceuticals S.p.A. (0QOI.L)?
What is the 5-year average ROE for Newron Pharmaceuticals S.p.A. (0QOI.L)?
How does the current ROE for Newron Pharmaceuticals S.p.A. (0QOI.L) compare to its historical average?